Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Watkins

Showing results (291-300 of 320) with videos related to

Pageof 32
Sort By:
Urologic Oncology|March 15, 2011
A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancerYoung E Whang, Andrew J Armstrong, W Kimryn Rathmell, et al.
Molecular and Cellular Endocrinology|February 1, 2015
Oxidation of the aromatic amino acids tryptophan and tyrosine disrupts their anabolic effects on bone marrow mesenchymal stem cellsMona El Refaey, Christopher P Watkins, Eileen J Kennedy, et al.
Circulation|November 4, 2005
Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathySaman Nazarian, David A Bluemke, Albert C Lardo, et al.
Breast Cancer Research and Treatment|April 17, 2013
Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancerMichelle A Rudek, Roisin M Connolly, Janelle M Hoskins, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2025
Single Cell Resolution Tracking of Cutaneous T-Cell Lymphoma Reveals Clonal Evolution in Disease ProgressionHannah K Dorando, Jared M Andrews, Nicholas C Borcherding, et al.
Hematological Oncology|April 22, 2025
Impact of Age on Biology, Presentation and Outcomes in Marginal Zone Lymphoma: Results From a Multicenter Cohort StudyPallawi Torka, Natalie S Grover, Timothy J Voorhees, et al.
Blood Advances|October 4, 2023
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort studyKaitlin Annunzio, Natalie S Grover, Rina Li Welkie, et al.
Haematologica|September 14, 2023
A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphomaTodd A Fehniger, Marcus P Watkins, Nkiruka Ezenwajiaku, et al.
Cancers|June 24, 2022
Metabolic Biomarkers Assessed with PET/CT Predict Sex-Specific Longitudinal Outcomes in Patients with Diffuse Large B-Cell LymphomaShama Jaswal, Vanessa Sanders, Priyanka Pullarkat, et al.
Nature|January 28, 2026
GlycoRNA complexed with heparan sulfate regulates VEGF-A signallingPeiyuan Chai, Sina Kheiri, Andrew Kuo, et al.
Pageof 32

Showing results (291-300 of 320) with videos related to

Sort By:
Pageof 32
Urologic Oncology|March 15, 2011
A phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancerYoung E Whang, Andrew J Armstrong, W Kimryn Rathmell, et al.
Molecular and Cellular Endocrinology|February 1, 2015
Oxidation of the aromatic amino acids tryptophan and tyrosine disrupts their anabolic effects on bone marrow mesenchymal stem cellsMona El Refaey, Christopher P Watkins, Eileen J Kennedy, et al.
Circulation|November 4, 2005
Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathySaman Nazarian, David A Bluemke, Albert C Lardo, et al.
Breast Cancer Research and Treatment|April 17, 2013
Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancerMichelle A Rudek, Roisin M Connolly, Janelle M Hoskins, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2025
Single Cell Resolution Tracking of Cutaneous T-Cell Lymphoma Reveals Clonal Evolution in Disease ProgressionHannah K Dorando, Jared M Andrews, Nicholas C Borcherding, et al.
Hematological Oncology|April 22, 2025
Impact of Age on Biology, Presentation and Outcomes in Marginal Zone Lymphoma: Results From a Multicenter Cohort StudyPallawi Torka, Natalie S Grover, Timothy J Voorhees, et al.
Blood Advances|October 4, 2023
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort studyKaitlin Annunzio, Natalie S Grover, Rina Li Welkie, et al.
Haematologica|September 14, 2023
A phase II study of interrupted and continuous dose lenalidomide in relapsed/refractory Hodgkin lymphomaTodd A Fehniger, Marcus P Watkins, Nkiruka Ezenwajiaku, et al.
Cancers|June 24, 2022
Metabolic Biomarkers Assessed with PET/CT Predict Sex-Specific Longitudinal Outcomes in Patients with Diffuse Large B-Cell LymphomaShama Jaswal, Vanessa Sanders, Priyanka Pullarkat, et al.
Nature|January 28, 2026
GlycoRNA complexed with heparan sulfate regulates VEGF-A signallingPeiyuan Chai, Sina Kheiri, Andrew Kuo, et al.
Pageof 32